PT  - JOURNAL ARTICLE
AU  - Sheikh, Abu Baker
AU  - Shekhar, Rahul
AU  - Javed, Nismat
AU  - Leyba, Katarina
AU  - Sheikh, Abdul Ahad Ehsan
AU  - Upadhyay, Shubhra
AU  - Kapuria, Devika
AU  - Cormier, Christopher
AU  - Rustagi, Tarun
TI  - Biliary Duct Hamartomas: A Systematic Review
AID  - 10.1101/2021.04.27.21256209
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.27.21256209
4099  - http://medrxiv.org/content/early/2021/04/30/2021.04.27.21256209.short
4100  - http://medrxiv.org/content/early/2021/04/30/2021.04.27.21256209.full
AB  - Biliary duct hamartomas are benign lesions of intrahepatic bile ducts. Oftentimes an incidental finding on imaging, these lesions can pose a diagnostic dilemma because of their overlapping features with malignant masses. We performed a structured systematic review of literature and identified 139 cases of biliary duct hamartomas. Patient demographics, clinical presentation with key laboratory and imaging findings, diagnostic modalities, management strategies, and outcomes were analyzed and systematically summarized. The systematic review is aimed to help with better understanding of biliary duct hamartomas and its principal features.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=230745 Funding StatementThere was no funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the guidelines of the Declaration of Helsinki, and presented fully anonymised non-identifiable information that did not require prior approval by the Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available on special request by the corresponding author.